|
|
|
||||||||||
Research Articles |
We retrospectively reviewed the postoperative hemorrhagic risk in patients undergoing surgery for coronary revascularization who had received platelet antiaggregants preoperatively. A significant increase in postoperative hemorrhage and a higher percentage of reoperations for this reason was observed in the patients treated with ticlopidine. However, there were no major differences in the platelet counts among the groups compared.
This article has been cited by other articles:
![]() |
S. Pothula, V. T. Sanchala, B. Nagappala, and M. A. Inchiosa Jr. The Effect of Preoperative Antiplatelet/Anticoagulant Prophylaxis on Postoperative Blood Loss in Cardiac Surgery Anesth. Analg., January 1, 2004; 98(1): 4 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kovesi and D. Royston Editorial I: Is there a bleeding problem with platelet-active drugs? Br. J. Anaesth., February 1, 2002; 88(2): 159 - 163. [Full Text] [PDF] |
||||
![]() |
G. L. Kaluza, J. Joseph, J. R. Lee, M. E. Raizner, and A. E. Raizner Catastrophic outcomes of noncardiac surgery soon after coronary stenting J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1288 - 1294. [Abstract] [Full Text] [PDF] |
||||